• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在实验性曼氏血吸虫病中,在姿势前期检测到的9-吖啶酮腙类药物的活性。

Activity of 9-acridanone-hydrazone drugs detected at the pre-postural phase, in the experimental schistosomiasis mansoni.

作者信息

Pereira L H, Coelho P M, Costa J O, de Mello R T

机构信息

Departamento de Parasitologia, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brasil.

出版信息

Mem Inst Oswaldo Cruz. 1995 May-Jun;90(3):425-8. doi: 10.1590/s0074-02761995000300021.

DOI:10.1590/s0074-02761995000300021
PMID:8544746
Abstract

The compound Ro-15.5458/000, derivative in the class of 9-acridanone-hydrazones, was found to be effective against Schistosoma mansoni in mice, killing almost all the skin schistosomules (24 hr after infection), when administered at the dose of 100 mg/kg. In experiments carried out with Cebus monkeys, the drug was shown to be fully effective at 25 mg/kg, 7 days after infection. These data, associated with the good results obtained earlier at the post-postural phase of schistosomiasis, allow the inference that this promising compound may be important in the set of antischistosomal drugs, depending on further toxicological and clinical tests.

摘要

化合物Ro-15.5458/000属于9-吖啶酮腙类衍生物,已发现其对感染曼氏血吸虫的小鼠有效,以100毫克/千克的剂量给药时,几乎能杀死所有皮肤期血吸虫幼虫(感染后24小时)。在用卷尾猴进行的实验中,该药物在感染后7天以25毫克/千克的剂量给药时显示出完全有效。这些数据,再加上早期在血吸虫病晚期阶段取得的良好结果,可以推断,这种有前景的化合物在抗血吸虫药物组中可能很重要,这取决于进一步的毒理学和临床试验。

相似文献

1
Activity of 9-acridanone-hydrazone drugs detected at the pre-postural phase, in the experimental schistosomiasis mansoni.在实验性曼氏血吸虫病中,在姿势前期检测到的9-吖啶酮腙类药物的活性。
Mem Inst Oswaldo Cruz. 1995 May-Jun;90(3):425-8. doi: 10.1590/s0074-02761995000300021.
2
Schistosoma mansoni: preclinical studies with 9-Acridanone-hydrazones in Cebus monkeys experimentally infected.
Rev Inst Med Trop Sao Paulo. 1991 Jan-Feb;33(1):50-7. doi: 10.1590/s0036-46651991000100010.
3
Antischistosomal activity of acridanone-hydrazones in Cebus monkeys experimentally infected with the SJ strain of Schistosoma mansoni.吖啶酮腙类化合物对实验感染曼氏血吸虫SJ株的卷尾猴的抗血吸虫活性
Rev Soc Bras Med Trop. 1995 Jul-Sep;28(3):179-83. doi: 10.1590/s0037-86821995000300003.
4
Efficacy of a new Hoffmann-La Roche compound (Ro 15-5458) against Schistosoma mansoni (Gezira strain, Sudan) in vervet monkeys (Cercopithecus aethiops).一种新型罗氏化合物(Ro 15 - 5458)对黑长尾猴(埃塞俄比亚猕猴)体内曼氏血吸虫(苏丹吉齐拉株)的疗效。
Trop Med Parasitol. 1989 Sep;40(3):335-6.
5
Parasitological evaluation of Ro 15-9268, a 9-acridanone-hydrazone derivative against Schistosoma mansoni in mice, and observations on changes in serum enzyme levels.罗 15-9268 对小鼠曼氏血吸虫的寄生虫学评价,一种 9-吖啶酮-腙衍生物,以及对血清酶水平变化的观察。
Parasitol Res. 2014 Jan;113(1):437-46. doi: 10.1007/s00436-013-3673-z. Epub 2013 Nov 22.
6
Parasitological evaluation of curative and subcurative doses of 9-acridanone-hydrazone drugs against Schistosoma mansoni in baboons, and observations on changes in serum levels of anti-egg antibodies detected by ELISA.对狒狒体内曼氏血吸虫使用9-吖啶酮腙类药物的治疗剂量和次治疗剂量进行寄生虫学评估,并观察酶联免疫吸附测定法检测的抗虫卵抗体血清水平变化。
Trans R Soc Trop Med Hyg. 1987;81(2):188-92. doi: 10.1016/0035-9203(87)90210-0.
7
Schistosoma mansoni: biochemical characteristics of the antischistosomal effects of Ro 15-5458.曼氏血吸虫:Ro 15-5458抗血吸虫作用的生化特性
Exp Parasitol. 1990 Jul;71(1):69-80. doi: 10.1016/0014-4894(90)90009-2.
8
Schistosoma mansoni: testis alterations induced by antischistosomal drug Ro15-5458.曼氏血吸虫:抗血吸虫药物Ro15 - 5458诱导的睾丸改变
J Egypt Soc Parasitol. 1999 Aug;29(2):325-34.
9
Efficacy, metabolism and pharmacokinetics of Ro 15-5458, a forgotten schistosomicidal 9-acridanone hydrazone.罗 15-5458 的疗效、代谢和药代动力学:一种被遗忘的杀血吸虫 9-吖啶酮腙。
J Antimicrob Chemother. 2020 Oct 1;75(10):2925-2932. doi: 10.1093/jac/dkaa247.
10
A note on the efficacy of a new class of compounds, 9-acridanone-hydrazones, against Schistosoma mansoni in a primate--the baboon.
Trans R Soc Trop Med Hyg. 1985;79(1):129-31. doi: 10.1016/0035-9203(85)90256-1.

引用本文的文献

1
Using ChEMBL to Complement Schistosome Drug Discovery.利用ChEMBL辅助血吸虫病药物研发。
Pharmaceutics. 2023 Apr 28;15(5):1359. doi: 10.3390/pharmaceutics15051359.
2
Schiff bases complexed with iron and their relation with the life cycle and infection by .Schiff 碱与铁的配合物及其与生命周期和感染的关系。
Front Immunol. 2022 Dec 21;13:1021768. doi: 10.3389/fimmu.2022.1021768. eCollection 2022.
3
Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?人类血吸虫病的化疗:我们已经取得了哪些进展?有什么新进展?我们从这里将走向何方?
RSC Med Chem. 2020 Apr 6;11(4):455-490. doi: 10.1039/d0md00062k. eCollection 2020 Apr 1.
4
Efficacy, metabolism and pharmacokinetics of Ro 15-5458, a forgotten schistosomicidal 9-acridanone hydrazone.罗 15-5458 的疗效、代谢和药代动力学:一种被遗忘的杀血吸虫 9-吖啶酮腙。
J Antimicrob Chemother. 2020 Oct 1;75(10):2925-2932. doi: 10.1093/jac/dkaa247.
5
Evaluation of the anti-Schistosoma mansoni activity of thiosemicarbazones and thiazoles.评价硫代卡巴肼和噻唑类化合物抗曼氏血吸虫的活性。
Antimicrob Agents Chemother. 2014;58(1):352-63. doi: 10.1128/AAC.01900-13. Epub 2013 Oct 28.
6
Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use.具有实验前景的抗血吸虫病药物:对一些未进入临床应用的候选药物的综述
Parasitol Res. 2009 Oct;105(4):899-906. doi: 10.1007/s00436-009-1546-2. Epub 2009 Jul 9.
7
Biological activities of hydrazone derivatives.腙衍生物的生物活性。
Molecules. 2007 Aug 17;12(8):1910-39. doi: 10.3390/12081910.
8
Schistosomiasis--a century searching for chemotherapeutic drugs.血吸虫病——一个世纪以来对化疗药物的探索
Parasitol Res. 2006 Oct;99(5):505-21. doi: 10.1007/s00436-006-0175-2. Epub 2006 Apr 25.